Skip to main content

Table 6 Cardiac function data comparison in model group and control group before TSH suppression treatment

From: Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma

 

Model group (n = 64)

Control group (n = 41)

P

EF (%)

83.01 ± 5.08

82.66 ± 5.53

0.073

PER (EDV/s)

4.67 ± 0.85

4.23 ± 0.44

0.051

PFR (EDV/s)

5.16 ± 0.94

5.40 ± 0.84

0.059

MFR/3 (EDV/s)

1.96 ± 0.63

2.16 ± 0.54

0.050

TTPF (ms)

179.06 ± 36.41

170.95 ± 23.33

0.331

BMP

90.80 ± 11.29

87.62 ± 6.37

0.789

Bandwidth

27.11 ± 11.42

28.95 ± 10.49

0.052

Mean angle (°)

201.52 ± 9.31

203.13 ± 8.97

0.968

Angle STD (°)

9.34 ± 6.01

9.00 ± 4.19

0.252

Entropy (%)

30.26 ± 10.26

29.28 ± 8.91

0.013

SRS

1.10 ± 0.42

0.99 ± 0.32

0.001

Reduced perfusion ratio (%)

26.67

29.03

–

  1. EF ejection fraction, PER peak ejection rate, EDV end-diastolic volume, PFR peak filling rate, MFR/3 mean filling rate over the first third of the end-systolic to end diastolic phase, TTPF time to peak filling from end-systole, BMP beats per minute, STD standard deviation, SRS summed rest score
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us